Press release
Viral Vectors and Plasmid DNA Manufacturing Market size is projected to reach $4,978.54 million by 2027, registering a CAGR of 24.9% from 2020 to 2027
According to a new report published by Report Ocean, titled, “Viral Vectors and Plasmid DNA Manufacturing Market by Product, Application, And Region: Opportunity Analysis and Industry Forecast, 2019-2027,”The viral vectors and plasmid DNA manufacturing market size was valued at $918.37 million in 2019 and is projected to reach $4,978.54 million by 2027, registering a CAGR of 24.9% from 2020 to 2027. North America was the highest contributor to the viral vectors and plasmid DNA manufacturing market in 2019; however, Asia-Pacific is anticipated to witness the fastest growth rate throughout the forecast period.
GET SAMPLE PAGES @ https://www.reportocean.com/industry-verticals/sample-request?report_id=AMR1251
Gene therapy has evolved as a favorable treatment option for various diseases (especially those with no cure at present) such as viral infections, cancers, and inherited disorders. Gene therapy and genetically modified therapy involve use of a therapeutic DNA (the gene of interest) in cells. The process of gene transfer into cells is achieved by application of vectors. Over the past few years, several viral and non-viral vectors (plasmid DNAs) have been standardized and optimized for this purpose. Viral vectors carry genetic material into cells by manipulating molecular mechanisms by which viruses transmit their genomes to other cells for infection. It can occur in vivo or in vitro. Plasmid carriers are artificially constructed on the basis of natural plasmids to adapt to laboratory operations.
This pandemic has disrupted growth in many economies across various domains. This pandemic is expected to present growth opportunities for viral vectors and plasmid DNA manufacturing market in near future. For this COVID-19, several viral vector, recombinant protein, live attenuated virus, and nucleic acid-based vaccines are in (pre)clinical development. Viral vector vaccines consist of a recombinant virus (which is the viral vector), frequently attenuated to reduce its pathogenicity, in which genes encoding viral antigen(s) have been cloned using recombinant DNA methods. Vector vaccines can either be replicating or non-replicating. The major advantage of these vector-based vaccines is that a single dose can be sufficient for protection. In addition, companies in the viral vector manufacturing market are increasing their production facilities.
Rise in funding for R&D activities pertaining to gene therapy; rise in prevalence of cancer, viral infection, & genetic disorders; and increase in awareness regarding gene therapy are the major factors that boost the viral vectors and plasmid DNA manufacturing market growth. However, high cost associated with gene therapies and risk of mutagenesis and other impediments in gene therapy restrain the market growth.
The impact of driving factors is expected to surpass that of the restraints. Moreover, rise in demand for synthetic genes and untapped potential for emerging markets are expected to provide new opportunities for market players in the future. However, possible insertional mutagenesis and high cost of gene therapies impede the market growth. Moreover, technological advancements to alleviate challenges caused by traditional methods of vector production provide lucrative opportunities for the manufacturers in the industry.
The cancer segment generated the highest revenue of in 2019, and is anticipated to continue this trend in the future. Requirement for quality drugs and versatile therapies for treatment are expected to boost growth of this segment. In addition, the inherited disorders segment is anticipated to grow at the highest CAGR from 2020 to 2027.
North America held the highest viral vectors and plasmid DNA manufacturing market share of million in 2019, owing to high prevalence rate of cancer and modern healthcare facilities. Adoption of experimental medicines and growth in awareness regarding gene therapy are expected to boost the North America market. Asia-Pacific is expected to grow at the highest CAGR during the forecast period, owing to rapid industrialization in the area, increase in disposable income, and surge in government initiatives to modernize healthcare infrastructure.
The global viral vectors and plasmid DNA manufacturing market is segmented on the basis of product, application, and region. On the basis of product, it is divided into plasmid DNA, viral vectors, and non-viral vectors. By application, it is categorized into cancer, inherited disorders, viral infections, and others. Region wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
Key Findings Of The Study
By product, the viral vector segment accounted for the largest market share in 2019.
By application, inherited disorder segment is expected to grow at the highest CAGR during the forecast period
North America held the major share of the viral vectors and plasmid DNA manufacturing market at CAGR of 23.4%.
The report provides some of the key players operating in the market include Cognate BioServices, Inc., Catalent Pharma Solutions, Fujifilm Holdings Corporation, Johnson & Johnson, Sanofi Corporation, F. Hoffmann-LA Roche Ltd, 4D Molecular Therapeutics, Sirion Biotech GmbH, Voyager therapeutics, and Thermo Fisher Scientific, Inc.
READ FULL REPORT @ https://www.reportocean.com/industry-verticals/sample-request?report_id=AMR1251
Get in Touch with Us:
Report Ocean
Email: sales@reportocean.com
Address: 500 N Michigan Ave, Suite 600, Chicago, IIIinois 60611 – UNITED STATES
Tel: +1 888 212 3539 (US – TOLL FREE)
Website: https://www.reportocean.com/
We are the best market research reports provider in the industry. Report Ocean believe in providing the quality reports to clients to meet the top line and bottom line goals which will boost your market share in today’s competitive environment. Report Ocean is “one-stop solution” for individuals, organizations, and industries that are looking for innovative market research reports.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Viral Vectors and Plasmid DNA Manufacturing Market size is projected to reach $4,978.54 million by 2027, registering a CAGR of 24.9% from 2020 to 2027 here
News-ID: 2248622 • Views: …
More Releases from Report Ocean

Japan Internet Advertising Market CAGR of 24.9%, Behind the Scenes Techniques fo …
The Japan Internet Advertising Market has demonstrated remarkable growth, reaching a valuation of USD 29.49 Billion in 2021. With the digital landscape continually evolving, it is forecasted to soar to an impressive USD 112.04 Billion by 2027. This surge represents an anticipated compound annual growth rate (CAGR) of 24.9% over the projected period, highlighting the dynamic and rapidly expanding nature of the digital advertising sector in Japan.
Internet Advertising are set…

Location Analytics Market Through the Looking Glass Techniques for a Profound Un …
This comprehensive market research report offers an in-depth analysis of the global location analytics market from 2019 to 2026. Valued at USD 10,813.6 million in 2019, the market is forecasted to surge to USD 29,878.5 million by 2026, demonstrating a robust Compound Annual Growth Rate (CAGR) of 15.6% throughout the projection period. This report delves into the key drivers, restraints, opportunities, and challenges that are shaping the market, providing stakeholders…

Affiliate Marketing Platform Market Eyes Wide Open Maximizing the Value of Obser …
The Global Affiliate Marketing Platform Market, valued at USD 19,217.4 million in 2021, is projected to witness significant growth over the next decade, reaching an estimated value of USD 36,902.1 million by 2030.
This report provides an in-depth analysis of the market dynamics, growth drivers, challenges, and opportunities that will influence the affiliate marketing landscape over the forecast period of 2021-2030. With a Compound Annual Growth Rate (CAGR) of 7.7%,…

Global Clear Brine Fluids Market Growth Forecast and Trends (2022-2030)
The global clear brine fluids market was valued at US$ 0.95 billion in 2021. It is anticipated to experience growth, reaching a valuation of US$ 1.39 billion by 2030. This growth trajectory translates to a compound annual growth rate (CAGR) of 3.1% during the forecast period from 2022 to 2030. Clear brine fluids, crucial in the oil and gas industry for drilling and completion processes, are poised for increased demand,…
More Releases for DNA
High-Quality Plasmid DNA Fuels Growth in Global DNA Plasmid Manufacturing Market
🌍 Market Overview
The DNA Plasmid Manufacturing Market is experiencing robust growth as advancements in cell & gene therapy, DNA vaccines, and genetic engineering continue to expand globally. Plasmid DNA plays a critical role as a raw material in the development of advanced therapies, fueling demand across biopharmaceutical research and production.
Key factors driving the market include:
Increasing adoption of gene and cell therapies
Rising prevalence of chronic and rare genetic disorders
Expansion of DNA-based…
DNA Synthesis Market Increasing Demand for Synthetic Genes and DNA Sequences
As demonstrated by Precision Business Insights (PBI), the latest report, the global DNA synthesis market was valued at USD 3,702.0 million in 2023 and is expected to reach USD 10,289.5 million by 2029, growing at a CAGR of 18.6% during the forecast period 2024-2030. The key drivers for the growth of the global DNA synthesis market include increasing demand for synthetic genes and DNA sequences, growing applications in the agriculture…
Wealth DNA Code Review Legit Price? (Wealth Manifestation DNA Code Audio Frequen …
Wealth DNA Code Wealth DNA Code is a digital program with seven minutes of soundtracks that manifest and listen to daily to activate the "Wealth DNA," which is part of your DNA to help you attract wealth by making money a part of your mentality and making your dreams to come true.
https://bit.ly/Visit-The-Official-Website-Here-To-Order-Wealth-DNA-Code
Making money, creating assets as well as increasing wealth are the primary objectives that every human being has to…
DNA Paternity Testing Market Size [2022-2029] -DNA Diagnostics Center, EasyDNA, …
A recent market research report added to repository of MR Accuracy Reports is an in-depth analysis of global DNA Paternity Testing. On the basis of historic growth analysis and current scenario of DNA Paternity Testing place, the report intends to offer actionable insights on global market growth projections. Authenticated data presented in report is based on findings of extensive primary and secondary research. Insights drawn from data serve as excellent…
DNA Paternity Testing Market Trends 2020 | Growth by Top Companies: DNA Diagnost …
The report begins with the overview of the DNA Paternity Testing Market and offers throughout development. It presents a comprehensive analysis of all the regional and major player segments that gives closer insights upon present market conditions and future market opportunities along with drivers, trending segments, consumer behaviour, pricing factors and market performance and estimation. The forecast market information, SWOT analysis, DNA Paternity Testing market scenario, and feasibility study are…
DNA Paternity Testing Market Rapidly Growing in Healthcare, Competitor Analysis …
The exclusive research report on the Global DNA Paternity Testing Market 2020 examines the market in detail along with focusing on significant market dynamics for the key players operating in the market. Global DNA Paternity Testing Industry research report offers granulated yet in-depth analysis of revenue share, market segments, revenue estimates and various regions across the globe.
Overview of Global DNA Paternity Testing Market:
This report studies the Global DNA Paternity Testing…